Neurostimulation device Market – Global Industry analysis and forecast (2023 – 2029)

Neurostimulation device Market is expected to grow at a CAGR of 8.15% during the forecast period and the market size is expected to reach nearly US$ 14.23 Bn by 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Global Neurostimulation MarketTo know about the Research Methodology   :- Request Free Sample Report Neurostimulation is the determined modulation of the nervous system's activity using invasive or non-invasive means. Neurostimulation usually refers to the nervous system in terms of electromagnetic methods. The rising prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, migraine, chronic lower back pain, dementias, and epilepsy will drive the Global Neurostimulation Devices Market size. In addition to this, a rising elderly patient base across the globe is another major factor that drives the industry growth as the geriatric patient pool is more unguarded to neurological disorders fuelling demand for neurostimulators in the future. Global Neurostimulation Devices Market is segmented by product, application, end user, region and geography. Global neurostimulation devices have the predominant usage in depression, dystonia, epilepsy, essential tremors, gastroparesis disorders, incontinence, obsessive compulsion disorders (ocd), pain, and Parkinson’s disease, thereby making it one of the most widely used devices segment in the world. North America, especially the U.S. will lead the Global Neurostimulation Devices Market over the current forecast period. Increasing extensiveness of neurological disorders, unruptured brain aneurysm, and chronic lower back pain are a few other factors that will stimulate demand for Global Neurostimulation Devices Market. The major players in the neurostimulation device market are Boston Scientific Corporation, Cyberonics Inc, St. Jude Medical Inc, Medtronic Inc., NeuroPace Inc., and NeuroSigma, Inc.

The years that have been considered for the study are:

• Base year – 2022 • Estimated year – 2023 • Forecast period – 2023 to 2029

Neurostimulation Market Key Highlights:

• Assessment of market definition along with the identification of key players and an analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2017 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities. • Global Neurostimulation Devices Market analysis and comprehensive segmentation with respect to the Product, Technology, Application, and geography to assist in strategic business planning. • Global Neurostimulation Devices Market analysis and forecast for five major geographies, North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and their key regions.

Neurostimulation Market Research Methodology

The market is estimated by analyzing the data points obtained from various sources and conducting them into a predictor model created specifically for each individual market. The data points are extracted from paid and unpaid sources along with paid primary interviews with key opinion leaders in the market. Key opinion leaders from both demand and supply sides of the market were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this analysis. This country-specific analysis was accumulated to establish regional numbers and then arrive at a global market value for Global Neurostimulation Market. The objective of the report is to present comprehensive Global Neurostimulation Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Neurostimulation Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Neurostimulation Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Neurostimulation Market  North America for Asia Pacific make the report investor’s guide. Research report categorizes the Global Neurostimulation Devices Market based on Product, Technology, Application and geography (region wise). Market size by value is estimated and forecasted with their venues of leading companies operating in the Global Oxygen Concentrators Market with key developments in companies and market trends.

Key target audience Global Neurostimulation Market

• Research and Consulting Firms as well as Venture capitalists, private equity firms, and start-up companies • Market leading companies • Product distributors • Raw material suppliers • Buyers • Government and regulatory authorities

Scope of the Global Neurostimulation Market: Inquire before buying

Global Neurostimulation Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2017 to 2022 Market Size in 2022: US $ 8.22 Bn.
Forecast Period 2023 to 2029 CAGR: 8.15% Market Size in 2029: US $ 14.23 Bn.
Segments Covered: by Product • Spinal Cord Stimulator • Deep Brain Stimulator • Sacral Nerve Stimulator • Vagus Nerve Stimulator • Gastric Electric Stimulator
by Application • Pain Management • Epilepsy • Essential Tremor • Urinary and Fecal Incontinence • Depression • Dystonia • Gastroparesis • Parkinson's Disease

Neurostimulation Market, by Region

North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)

Neurostimulation Market Key Players are:

• Nevro • NeuroPace, Inc. • MED-EL. • Aleva Neurotherapeutics SA • BioControl Medical • Bioness Inc • EnteroMedics Inc • Nevro Corporation • Autonomic Technologies • Multi Radiance Medical, Inc • Neuronetics, Inc • American Imex • Amrex Electrotherapy Equipment • Electromedical Products International (EPI) • Medtronic • Boston Scientific Corporation • Abbott • LivaNova • Synapse Biomedical, Inc. • NeuroSigma • GTX Medical • Integer Holdings Corporation Frequently Asked questions 1. Which region has the largest share in Global Neurostimulation Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Neurostimulation Market? Ans: The Global Neurostimulation Market is growing at a CAGR of 8.15% during forecasting period 2023-2029. 3. What is scope of the Global Neurostimulation Market report? Ans: Global Neurostimulation Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Neurostimulation Market? Ans: The important key players in the Global Neurostimulation Market are – Nevro, NeuroPace, Inc. MED-EL,. Aleva, Neurotherapeutics, SA BioControl Medical, Bioness Inc, EnteroMedics Inc, Nevro Corporation, Autonomic Technologies, Multi Radiance Medical, Inc Neuronetics, Inc.. 5. What is the study period of this Market? Ans: The Global Neurostimulation Market is studied from 2022 to 2029.
1. INTRODUCTION 1.1. Market description & Scope ( 2022-2029) 1.2. Objectives 1.2.1. Key Takeaways 1.2.2. Abbreviations & Acronyms 2. RESEARCH METHODOLOGY 2.1. Methods used for market forecasting 2.2. Data Sources 2.2.1. Paid Databases 2.2.2. Primary Sources 2.2.3. Secondary Sources 3. EXECUTIVE SUMMARY 3.1. Major Findings 3.1.1. Key Segment Trends 3.1.1.1. Product 3.1.1.2. Application 3.1.2. Key Regional Trends 3.1.2.1. North America 3.1.2.2. Europe 3.1.2.3. Asia Pacific 3.1.2.4. RoW 3.2. Key Companies and their Strategies 4. MARKET OVERVIEW 4.1. Neurostimulation Devices Concept & Definition 4.2. Segments Overview 4.2.1. By Product 4.2.1.1. Spinal Cord Stimulator 4.2.1.2. Deep Brain Stimulator 4.2.1.3. Sacral Nerve Stimulator 4.2.1.4. Vagus Nerve Stimulator 4.2.1.5. Gastric Electric Stimulator 4.2.2. By Application 4.2.2.1. Pain Management 4.2.2.2. Epilepsy 4.2.2.3. Essential Tremor 4.2.2.4. Urinary and Fecal Incontinence 4.2.2.5. Depression 4.2.2.6. Dystonia 4.2.2.7. Gastroparesis 4.2.2.8. Parkinson's Disease 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Porter’s Analysis 4.5. PESTLE Analysis 4.6. Fragmentation 4.6.1. Key strategic Alliances of companies (inorganic & organic) 4.6.2. Company Market Share (Top 10 Players) 4.6.3. Comparative Analysis of Key players in Neurostimulation Devices 4.7. Key Trends 4.8 Key Trends in Global Neurostimulation Device Market 5. GLOBAL NEUROSTIMULATION DEVICES PRODUCT ESTIMATES & TREND ANALYSIS ( 2022-2029) 5.1. Global Neurostimulation Devices Market: Product Analysis 5.1.1. Spinal Cord Stimulator 5.1.1.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 5.1.2. Deep Brain Stimulator 5.1.2.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 5.1.3. Sacral Nerve Stimulator 5.1.3.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 5.1.4. Vagus Nerve Stimulator 5.1.4.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 5.1.5. Gastric Electric Stimulator 5.1.5.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 5.2. Global Neurostimulation Devices Market: Product Trends 6. GLOBAL NEUROSTIMULATION DEVICES APPLICATION ESTIMATES & TREND ANALYSIS ( 2022-2029) 6.1. Global Neurostimulation Devices Market: Application Analysis 6.1.1. Pain Management 6.1.1.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 6.1.2. Epilepsy 6.1.2.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 6.1.3. Essential Tremor 6.1.3.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 6.1.4. Urinary and Fecal Incontinence 6.1.4.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 6.1.5. Depression 6.1.5.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 6.1.6. Dystonia 6.1.6.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 6.1.7. Gastroparesis 6.1.7.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 6.1.8. Parkinson's Disease 6.1.8.1. Market Share and growth forecasts, 2022-2029 (USD Billion) 6.2. Global Neurostimulation Devices Market: Application Trends 7. REGIONAL ESTIMATES & TREND ANALYSIS ( 2022-2029) 7.1. Global Neurostimulation Devices market share by Region, 2016 & 2025 7.2. North America 7.2.1. North America Neurostimulation Devices market, Market Share and growth forecasts, 2022-2029 (USD Billion) 7.2.2. Neurostimulation Devices Drivers For North America Market 7.2.3. Market Share Analysis and Growth Forecast, by Country 7.2.3.1. US 7.2.3.2. Canada 7.2.4. Country-wise GDP Growth Forecast 7.2.5. Neurostimulation Devices Trends In North America Market 7.3. Europe 7.3.1. Europe Neurostimulation Devices market, Market Share and growth forecasts, 2022-2029 (USD Billion) 7.3.2. Neurostimulation Devices Drivers For Europe Market 7.3.3. Market Share Analysis and Growth Forecast, by Country 7.3.3.1. UK 7.3.3.2. Germany 7.3.3.3. France 7.3.3.4. Russia 7.3.3.5. Spain 7.3.3.6. Italy 7.3.3.7. Others 7.3.4. Country-wise GDP Growth Forecast 7.3.5. Neurostimulation Devices Trends In Europe Market 7.4. Asia Pacific 7.4.1. Asia Pacific Neurostimulation Devices market, Market Share and growth forecasts, 2022-2029 (USD Billion) 7.4.2. Neurostimulation Devices Drivers For Asia Pacific Market 7.4.3. Market Share Analysis and Growth Forecast, by Country 7.4.3.1. China 7.4.3.2. Japan 7.4.3.3. India 7.4.3.4. South Korea 7.4.3.5. Australia 7.4.3.6. Others 7.4.4. Country-wise GDP Growth Forecast 7.4.5. Neurostimulation Devices Trends In Asia Pacific Market 7.5. RoW 7.5.1. RoW Neurostimulation Devices market, Market Share and growth forecasts, 2022-2029 (USD Billion) 7.5.2. Neurostimulation Devices Drivers For LAMEA Market 7.5.3. Market Share Analysis and Growth Forecast, by Country 7.5.3.1. GCC Countries 7.5.3.2. Saudi Arabia 7.5.3.3. Brazil 7.5.3.4. Mexico 7.5.3.5. Others 7.5.4. Country-wise GDP Growth Forecast 7.5.5. Neurostimulation Devices Trends In RoW Market 8. MARKET SHARE ANALYSIS 8.1. Key Players Regional Market share Analysis 8.1.1. North America 8.1.2. Europe 8.1.3. Asia Pacific 8.1.4. RoW 9. MARKET COMPETITION ANALYSIS 9.1. Strategy Framework 9.2. Consolidation 9.2.1. Patent Analysis 9.2.2. Mergers & Acquisitions 9.2.2.1. Product Based 9.2.2.2. Services Based 9.2.2.3. Region Based 9.2.2.4. List of Mergers & Acquisitions 9.2.3. Company Benchmarking (Revenue & Profit Based) 9.2.4. Strategic Assessment of Company Consolidations 9.2.5. Emerging Business Models 9.3. Company Profiles 9.3.1. Boston Scientific Corporation 9.3.1.1. Company overview 9.3.1.2. Key financials 9.3.1.3. Geographical presence 9.3.1.4. Product and Business Segments 9.3.1.5. Strategic initiatives 9.3.1.6. SWOT analysis 9.3.1.7. Competitive positioning and landscape 9.3.2. Cyberonics Inc 9.3.2.1. Company overview 9.3.2.2. Key financials 9.3.2.3. Geographical presence 9.3.2.4. Product and Business Segments 9.3.2.5. Strategic initiatives 9.3.2.6. SWOT analysis 9.3.2.7. Competitive positioning and landscape 9.3.3. St. Jude Medical Inc 9.3.3.1. Company overview 9.3.3.2. Key financials 9.3.3.3. Geographical presence 9.3.3.4. Product and Business Segments 9.3.3.5. Strategic initiatives 9.3.3.6. SWOT analysis 9.3.3.7. Competitive positioning and landscape 9.3.4. Medtronic Inc. 9.3.4.1. Company overview 9.3.4.2. Key financials 9.3.4.3. Geographical presence 9.3.4.4. Product and Business Segments 9.3.4.5. Strategic initiatives 9.3.4.6. SWOT analysis 9.3.4.7. Competitive positioning and landscape 9.3.5. NeuroPace Inc. 9.3.5.1. Company overview 9.3.5.2. Key financials 9.3.5.3. Geographical presence 9.3.5.4. Product and Business Segments 9.3.5.5. Strategic initiatives 9.3.5.6. SWOT analysis 9.3.5.7. Competitive positioning and landscape 9.3.6. NeuroSigma, Inc 9.3.6.1. Company overview 9.3.6.2. Key financials 9.3.6.3. Geographical presence 9.3.6.4. Product and Business Segments 9.3.6.5. Strategic initiatives 9.3.6.6. SWOT analysis 9.3.6.7. Competitive positioning and landscape 9.3.7. MED-EL 9.3.7.1. Company overview 9.3.7.2. Key financials 9.3.7.3. Geographical presence 9.3.7.4. Product and Business Segments 9.3.7.5. Strategic initiatives 9.3.7.6. SWOT analysis 9.3.7.7. Competitive positioning and landscape 9.3.8. Nevro 9.3.8.1. Company overview 9.3.8.2. Key financials 9.3.8.3. Geographical presence 9.3.8.4. Product and Business Segments 9.3.8.5. Strategic initiatives 9.3.8.6. SWOT analysis 9.3.8.7. Competitive positioning and landscape 9.3.9. Aleva Neurotherapeutics SA 9.3.9.1. Company overview 9.3.9.2. Key financials 9.3.9.3. Geographical presence 9.3.9.4. Product and Business Segments 9.3.9.5. Strategic initiatives 9.3.9.6. SWOT analysis 9.3.9.7. Competitive positioning and landscape 9.3.10. BioControl Medical 9.3.10.1. Company overview 9.3.10.2. Key financials 9.3.10.3. Geographical presence 9.3.10.4. Product and Business Segments 9.3.10.5. Strategic initiatives 9.3.10.6. SWOT analysis 9.3.10.7. Competitive positioning and landscape 9.3.11. Bioness Inc 9.3.11.1. Company overview 9.3.11.2. Key financials 9.3.11.3. Geographical presence 9.3.11.4. Product and Business Segments 9.3.11.5. Strategic initiatives 9.3.11.6. SWOT analysis 9.3.11.7. Competitive positioning and landscape 9.3.12. EnteroMedics Inc 9.3.12.1. Company overview 9.3.12.2. Key financials 9.3.12.3. Geographical presence 9.3.12.4. Product and Business Segments 9.3.12.5. Strategic initiatives 9.3.12.6. SWOT analysis 9.3.12.7. Competitive positioning and landscape 9.3.13. Autonomic Technologies 9.3.13.1. Company overview 9.3.13.2. Key financials 9.3.13.3. Geographical presence 9.3.13.4. Product and Business Segments 9.3.13.5. Strategic initiatives 9.3.13.6. SWOT analysis 9.3.13.7. Competitive positioning and landscape 9.3.14. Multi Radiance Medical, Inc 9.3.14.1. Company overview 9.3.14.2. Key financials 9.3.14.3. Geographical presence 9.3.14.4. Product and Business Segments 9.3.14.5. Strategic initiatives 9.3.14.6. SWOT analysis 9.3.14.7. Competitive positioning and landscape 9.3.15. Neuronetics, Inc 9.3.15.1. Company overview 9.3.15.2. Key financials 9.3.15.3. Geographical presence 9.3.15.4. Product and Business Segments 9.3.15.5. Strategic initiatives 9.3.15.6. SWOT analysis 9.3.15.7. Competitive positioning and landscape 9.3.16. Amrex Electrotherapy Equipment 9.3.16.1. Company overview 9.3.16.2. Key financials 9.3.16.3. Geographical presence 9.3.16.4. Product and Business Segments 9.3.16.5. Strategic initiatives 9.3.16.6. SWOT analysis 9.3.16.7. Competitive positioning and landscape 9.3.17. Electromedical Products International (EPI) 9.3.17.1. Company overview 9.3.17.2. Key financials 9.3.17.3. Geographical presence 9.3.17.4. Product and Business Segments 9.3.17.5. Strategic initiatives 9.3.17.6. SWOT analysis 9.3.17.7. Competitive positioning and landscape 9.3.18. Neuronetics, Inc 9.3.18.1. Company overview 9.3.18.2. Key financials 9.3.18.3. Geographical presence 9.3.18.4. Product and Business Segments 9.3.18.5. Strategic initiatives 9.3.18.6. SWOT analysis 9.3.18.7. Competitive positioning and landscape
  • INQUIRE BEFORE BUYING